Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients.

BACKGROUND Hyperhomocysteinemia and the metabolic syndrome are established cardiovascular risk factors and are frequently associated with hypertension. The relationship of plasma homocysteine (Hcy) with the metabolic syndrome and insulin resistance, however, is debated and studies in hypertensive patients are limited. In this study, we have investigated the association of Hcy with the metabolic syndrome and cerebro- cardiovascular events in hypertension. METHODS In 562 essential hypertensive patients who underwent accurate assessment of fasting and postload glucose metabolism, insulin sensitivity, and renal function, we measured plasma levels of Hcy, vitamin B12, folate, and fibrinogen and assessed the prevalence of the metabolic syndrome and of coronary heart and cerebrovascular disease (CVD). RESULTS Patients with the metabolic syndrome had significantly higher plasma Hcy levels. After correction for covariates, increasing Hcy levels were associated with an increasing prevalence of the metabolic syndrome, coronary heart disease, and CVD. Plasma Hcy was directly correlated with age, waist circumference, fasting glucose, triglyceride, uric acid, and fibrinogen levels, and homeostatic model assessment index and inversely with creatinine clearance and high-density lipoprotein cholesterol, vitamin B12, and folate levels. Logistic regression analysis showed an independent association of Hcy levels with age, male gender, vitamin B12 and folate levels, and the metabolic syndrome. Logistic regression indicated also an independent association of Hcy with cerebro-cardiovascular disease that was independent of the metabolic syndrome. CONCLUSIONS Elevated plasma Hcy is associated with the metabolic syndrome in hypertensive patients. Prevalence of events increases with increasing plasma Hcy levels suggesting a contribution of Hcy to cerebro-cardiovascular diseases in these patients.

[1]  L. Sechi,et al.  Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients. , 2013, American journal of hypertension.

[2]  M. Jakovljevič,et al.  Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics , 2011, Psychiatry Research.

[3]  R. Collins,et al.  Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. , 2010, Archives of internal medicine.

[4]  S. Kurtoğlu,et al.  Is plasma homocysteine level associated with metabolic syndrome components in adolescents? , 2009, Metabolic syndrome and related disorders.

[5]  I. Nabipour,et al.  The metabolic syndrome is not associated with homocysteinemia: The Persian Gulf Healthy Heart Study , 2009, Journal of endocrinological investigation.

[6]  M. Novello,et al.  Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage. , 2008, American journal of hypertension.

[7]  T. Gungor,et al.  The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome , 2008, The journal of obstetrics and gynaecology research.

[8]  K. Sung,et al.  Relationship between metabolic syndrome categorized by newly recommended by International Diabetes Federation criteria with plasma homocysteine concentration. , 2007, Endocrine journal.

[9]  M. Ciaccio,et al.  Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease , 2007, Therapeutics and clinical risk management.

[10]  L. Sechi,et al.  Relationships of plasma renin levels with renal function in patients with primary aldosteronism. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[11]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[12]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[13]  Victor M Montori,et al.  Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. , 2007, Journal of the American College of Cardiology.

[14]  I. Lemieux,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[15]  L. Råstam,et al.  Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project. , 2006, Metabolism: clinical and experimental.

[16]  N. Stefan,et al.  Plasma homocysteine concentrations in young individuals at increased risk of type 2 diabetes are associated with subtle differences in glomerular filtration rate but not with insulin resistance. , 2006, Experimental and clinical endocrinology & diabetes.

[17]  H. Esgin,et al.  The relationship between the levels of plasma total homocysteine and insulin resistance in uncomplicated mild-to-moderate primary hypertension , 2006, Journal of Human Hypertension.

[18]  Y. van der Graaf,et al.  Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome , 2005, Heart.

[19]  A. Guven,et al.  Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome , 2005, Heart and Vessels.

[20]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[21]  C. Catena,et al.  Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal. , 2005, Alcoholism, clinical and experimental research.

[22]  M. Stipanuk.  Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. , 2004, Annual review of nutrition.

[23]  S. Tyagi,et al.  Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleiotropic effects of folate supplementation , 2004, Nutrition journal.

[24]  Ben-Ami Sela,et al.  Hyperhomocysteinemia as a component of syndrome X. , 2003, Metabolism: clinical and experimental.

[25]  L. Sechi,et al.  Serum lipoprotein(a) concentrations and alcohol consumption in hypertension: possible relevance for cardiovascular damage , 2003, Journal of hypertension.

[26]  J. Zvárová,et al.  Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins. , 2002, American journal of hypertension.

[27]  D. Singer,et al.  Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. , 2001, Diabetes care.

[28]  I. Godsland,et al.  Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. , 2001, The Journal of clinical endocrinology and metabolism.

[29]  C. Catena,et al.  Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. , 2000, The American journal of medicine.

[30]  C. Catena,et al.  Increased Fibrinogen Levels and Hemostatic Abnormalities in Patients with Arteriolar Nephrosclerosis: Association with Cardiovascular Events , 2000, Thrombosis and Haemostasis.

[31]  L. Fink,et al.  Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. , 2000, Metabolism: clinical and experimental.

[32]  G. Reaven,et al.  Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. , 1999, Atherosclerosis.

[33]  S. Ebrahim,et al.  Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men , 1995, The Lancet.

[34]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[35]  A. Melis,et al.  Insulin hypersecretion: a distinctive feature between essential and secondary hypertension. , 1992, Metabolism: clinical and experimental.

[36]  F. Azizi,et al.  The relationship between metabolic syndrome, cardiometabolic risk factors and inflammatory markers in a Tehranian population: the Tehran Lipid and Glucose Study. , 2012, Internal medicine.

[37]  E. Solá,et al.  Homocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistance. , 2012, Clinical hemorheology and microcirculation.

[38]  D. Corella,et al.  Homocysteine levels and the metabolic syndrome in a Mediterranean population: a case-control study. , 2011, Clinical hemorheology and microcirculation.

[39]  B. Bauduceau,et al.  Is hyperhomocysteinemia an additional risk factor of the metabolic syndrome? , 2006, Metabolic syndrome and related disorders.

[40]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[41]  W. Sheu,et al.  Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. , 2000, American journal of hypertension.